Related references
Note: Only part of the references are listed.Targeting TDP-43 proteinopathy with drugs and drug-like small molecules
Emanuele Buratti
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis
Donya Pakravan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2021)
NMR assignments for the C-terminal domain of human TDP-43
David Pantoja-Uceda et al.
BIOMOLECULAR NMR ASSIGNMENTS (2021)
Tethering-induced destabilization and ATP-binding for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1
Mei Dang et al.
SCIENTIFIC REPORTS (2021)
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Salvatore Spina et al.
BRAIN (2021)
Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation
Paraskevi Tziortzouda et al.
NATURE REVIEWS NEUROSCIENCE (2021)
Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43
Qiuye Li et al.
NATURE COMMUNICATIONS (2021)
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
Eva Maria Johanna de Boer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
ATP is a cryptic binder of TDP-43 RRM domains to enhance stability and inhibit ALS/AD-associated fibrillation
Mei Dang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain
Mei Dang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Modulating ALS-Related Amyloidogenic TDP-43307-319 Oligomeric Aggregates with Computationally Derived Therapeutic Molecules
Veronica Laos et al.
BIOCHEMISTRY (2020)
Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-432C-A315T by AIM4
Amandeep Girdhar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology
P. Bourassa et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
TDP-43 α-helical structure tunes liquid-liquid phase separation and function
Alexander E. Conicella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Prion-like properties of assembled TDP-43
Takashi Nonaka et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2020)
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose et al.
CANCERS (2020)
Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases
Gareth S. A. Wright et al.
ISCIENCE (2020)
An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties
Niloufar Mollasalehi et al.
ACS CHEMICAL BIOLOGY (2020)
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
Myungjin Jo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy
Casey N. Cook et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases
Chunhui Huang et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Small molecules as potent biphasic modulators of protein liquid-liquid phase separation
W. Michael Babinchak et al.
NATURE COMMUNICATIONS (2020)
To Be or Not To Be horizontal ellipsis Toxic-Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?
Suvithanandhini Loganathan et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology
Silvia Pozzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
Jacob R. Mann et al.
NEURON (2019)
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Archana Prasad et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Rudolf C. Hergesheimer et al.
BRAIN (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
Piecing together a consensus on a TDP43-related dementia syndrome
Heather Wood
NATURE REVIEWS NEUROLOGY (2019)
An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration
Brittany N. Flores et al.
CELL REPORTS (2019)
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
Britt A. Berning et al.
FRONTIERS IN NEUROSCIENCE (2019)
Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)
Liberty Francois-Moutal et al.
ACS CHEMICAL BIOLOGY (2019)
Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration
Mirella Vivoli Vega et al.
FASEB JOURNAL (2019)
NMR Fragment-Based Screening against Tandem RNA Recognition Motifs of TDP-43
Gilbert Nshogoza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cryo-EM structures of four polymorphic TDP-43 amyloid cores
Qin Cao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD
Mark Y. Fang et al.
NEURON (2019)
Liquid–Liquid Phase Separation in Disease
Simon Alberti et al.
Annual Review of Genetics (2019)
RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy
Han-Jou Chen et al.
BRAIN (2019)
Phase separation-deficient TDP43 remains functional in splicing
Hermann Broder Schmidt et al.
NATURE COMMUNICATIONS (2019)
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates
Florent Laferriere et al.
NATURE NEUROSCIENCE (2019)
Structural Insights Into TDP-43 and Effects of Post-translational Modifications
Liberty Francois-Moutal et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Structure-based inhibitors of tau aggregation
P. M. Seidler et al.
NATURE CHEMISTRY (2018)
The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43
Hao-Ru Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2018)
A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing
Ailin Wang et al.
EMBO JOURNAL (2018)
TDP-43 post-translational modifications in health and disease
Emanuele Buratti
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues
Hao-Ru Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation
Elizabeth L. Guenther et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation
Elizabeth L. Guenther et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS Pathogenesis
Davide Tavella et al.
BIOPHYSICAL JOURNAL (2018)
Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization
Leeanne McGurk et al.
MOLECULAR CELL (2018)
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S. Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation
Leeanne McGurk et al.
BIOCHEMISTRY (2018)
Age-related deregulation of TDP-43 after stroke enhances NF-B-mediated inflammation and neuronal damage
Sai Sampath Thammisetty et al.
JOURNAL OF NEUROINFLAMMATION (2018)
The RNA-Recognition Motifs of TAR DNA-Binding Protein 43 May Play a Role in the Aberrant Self-Assembly of the Protein
Elsa Zacco et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis
Qinghai Zeng et al.
CANCER BIOLOGY & THERAPY (2017)
Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions
Miguel Mompean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
Cyntia Tremblay et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Liquid phase condensation in cell physiology and disease
Yongdae Shin et al.
SCIENCE (2017)
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
Tariq Afroz et al.
NATURE COMMUNICATIONS (2017)
The roles of intrinsic disorder-based liquid-liquid phase transitions in the Dr. Jekyll-Mr. Hyde behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Vladimir N. Uversky
AUTOPHAGY (2017)
Impact of multiple pathologies on the threshold for clinically overt dementia
Alifiya Kapasi et al.
ACTA NEUROPATHOLOGICA (2017)
Phase to Phase with TDP-43
Yulong Sun et al.
BIOCHEMISTRY (2017)
Structural Studies of Amyloid Proteins at the Molecular Level
David S. Eisenberg et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86 (2017)
The TDP-43 N-terminal domain structure at high resolution
Miguel Mompean et al.
FEBS JOURNAL (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins
Antonia Ratti et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation
Lei-Lei Jiang et al.
SCIENTIFIC REPORTS (2016)
A molecular mechanism realizing sequence-specific recognition of nucleic acids by TDP-43
Yoshiaki Furukawa et al.
SCIENTIFIC REPORTS (2016)
ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43
Liangzhong Lim et al.
PLOS BIOLOGY (2016)
An acridine derivative, [4,5-bis {(N-carboxy methyl imidazolium) methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models
Archana Prasad et al.
SCIENTIFIC REPORTS (2016)
Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization
Amandine Molliex et al.
CELL (2015)
Curcumin Binding to Beta Amyloid: A Computational Study
Praveen P. N. Rao et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Emma L. Scotter et al.
NEUROTHERAPEUTICS (2015)
TDP-43 is a key player in the clinical features associated with Alzheimer's disease
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2014)
Structural characterization of the minimal segment of TDP-43 competent for aggregation
Miguel Mompean et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Classification of Intrinsically Disordered Regions and Proteins
Robin van der Lee et al.
CHEMICAL REVIEWS (2014)
Self-Assembling Properties of Peptides Derived from TDP-43 C-Terminal Fragment
Akash Saini et al.
LANGMUIR (2014)
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Sami J. Barmada et al.
NATURE CHEMICAL BIOLOGY (2014)
The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids
Pan-Hsien Kuo et al.
NUCLEIC ACIDS RESEARCH (2014)
Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life
James A. Austin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA
Haina Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Lies Vanden Broeck et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Tau-Derived-Hexapeptide 306VQIVYK311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design
Tarek Mohamed et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
Allison S. Limpert et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2013)
RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy
Ryoko Ihara et al.
HUMAN MOLECULAR GENETICS (2013)
Structural Transformation of the Amyloidogenic Core Region of TDP-43 Protein Initiates Its Aggregation and Cytoplasmic Inclusion
Lei-Lei Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Poly(4-styrenesulfonate) as an Inhibitor of Aβ40 Amyloid Fibril Formation
Bimlesh Ojha et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43
Peter J. Lukavsky et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains
Takashi Nonaka et al.
CELL REPORTS (2013)
The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity
Chung-ke Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration
Chantelle F. Sephton et al.
BIOLOGICAL CHEMISTRY (2012)
The Amyloid State of Proteins in Human Diseases
David Eisenberg et al.
CELL (2012)
Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms
Daniel F. Tardiff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Edward B. Lee et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes
Sarah J. Parker et al.
PLOS ONE (2012)
TDP-43: gumming up neurons through protein-protein and protein-RNA interactions
Emanuele Buratti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies
I. -Fan Wang et al.
NATURE COMMUNICATIONS (2012)
The Amyloid-Congo Red Interface at Atomic Resolution
Anne K. Schuetz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease
Cyntia Tremblay et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
NEURODEGENERATIVE DISEASE A target map for TDP43
Katherine Whalley
NATURE REVIEWS NEUROSCIENCE (2011)
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity
Weirui Guo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Implications of the prion-related Q/N domains in TDP-43 and FUS
Maria Udan et al.
PRION (2011)
Towards a Pharmacophore for Amyloid
Meytal Landau et al.
PLOS BIOLOGY (2011)
TDP-43 Dimerizes in Human Cells in Culture
Yuki Shiina et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development
Chantelle F. Sephton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity
Aaron Voigt et al.
PLOS ONE (2010)
Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism
Po-Min Chiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® Technology
Joel A. Cassel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
Makiko Yamashita et al.
FEBS LETTERS (2009)
Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43
Takashi Nonaka et al.
HUMAN MOLECULAR GENETICS (2009)
Structural insights into TDP-43 in nucleic-acid binding and domain interactions
Pan-Hsien Kuo et al.
NUCLEIC ACIDS RESEARCH (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Yong-Jie Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia
Ian R. A. Mackenzie et al.
CURRENT OPINION IN NEUROLOGY (2008)
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation
Matthew J. Winton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural determinants of the cellular localization and shuttling of TDP-43
Youhna M. Ayala et al.
JOURNAL OF CELL SCIENCE (2008)
Concomitant TAR-DNA-binding in Alzheimer disease and protein 43 pathology is present corticobasal degeneration but not in other tauopathies
Kunihiro Uryu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDR-43 aggregation and cellular toxicity
Brian S. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis - Protein misfolding diseases without amyloidosis
Manuela Neumann et al.
ARCHIVES OF NEUROLOGY (2007)
Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43
Yong-Jie Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Michael J. Strong et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Catalina Amador-Ortiz et al.
ANNALS OF NEUROLOGY (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Structural diversity and functional implications of the eukaryotic TDP gene family
HY Wang et al.
GENOMICS (2004)
Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9
E Buratti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
E Buratti et al.
EMBO JOURNAL (2001)
Share Paper
